In the news | 16th December 2016

A Year in review from IDBS

Tomorrow’s Laboratories

2016 was a busy year for the pharmaceutical industry and Scott Weiss, Vice President of Product Strategy, reviews some of the industry’s interesting talking points.

Read more

About IDBSContact us

More news

Shutterstock 1899051346 Scaled 768x512

Beating the Capacity Crunch: Rethinking the Biopharma Supply Chain to Avoid Shortages

One of the lasting legacies of the COVID-19 pandemic is heightened awareness of manufacturing challenges and supply chain vulnerabilities in the biopharma industry and the impact this can have on public health. Issues have occurred at every stage of the supply chain, from the availability of raw materials to quality concerns with active pharmaceutical ingredients (APIs), and finished dosage forms and restrictive cold chain requirements.

Read more